GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kilitch Drugs India Ltd

Kilitch Drugs approves 1:1 bonus — share capital doubles to Rs. 34.96 Crore

BONUS ▲ Positive Development LOW RISK
📅 Filed on BSE: 25 Mar 2026, 12:20 PM IST  ·  BSE ID: 7c610964-340e-485a-a849-ba969c8df095
View Original BSE Filing (PDF)
💡
In Simple Terms
Kilitch Drugs gave every shareholder one free new share for each share they already owned, doubling share count.
🤖 AI Summary
  • Board approved allotment of 1,74,80,782 bonus equity shares in 1:1 ratio on 25 March 2026
  • Record date fixed at 24 March 2026; existing shareholders eligible for bonus issuance
  • Paid-up share capital increased from Rs. 17,48,07,820 to Rs. 34,96,15,640
  • Bonus shares rank pari-passu with existing fully paid-up equity shares
🔢 Key Numbers - exact figures from BSE filing, not rounded
Bonus equity shares allotted
1,74,80,782 shares
Bonus ratio
1:1
Face value per share
Rs. 10
Paid-up capital (pre-bonus)
Rs. 17,48,07,820
Paid-up capital (post-bonus)
Rs. 34,96,15,640
Total shares post-bonus
34,961,564 shares
🏢 How This Affects the Company
💰
Financial Impact
Paid-up equity share capital doubled from Rs. 17,48,07,820 to Rs. 34,96,15,640. No cash outflow. Earnings per share diluted proportionally; book value per share halves unless retained earnings increase.
👥 What This Means For Shareholders
✅
Action Required
No action required. Bonus credited automatically to demat accounts of shareholders holding shares on record date 24 March 2026.
👤
Who Is Affected
All shareholders who held equity shares as of 24 March 2026 receive one bonus share per share held. Total shareholder count increases; individual ownership percentage remains unchanged.
🔍
Management Signal
Board is improving stock accessibility and retail participation through capital restructuring without diluting ownership stakes.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Credit of bonus shares to demat accounts within 7-10 days of board approval
Stock exchange index adjustment and ex-bonus trading launch date confirmation
Next quarterly results to assess EPS impact and earnings growth trajectory
LOW RISK Bonus issuance is routine capital restructuring. No financial or operational risk. Completed board decision with clear record date.
💡 Investor Takeaway
Kilitch Drugs doubled share count via 1:1 bonus on record date 24 March 2026. Paid-up capital increased from Rs. 17,48,07,820 to Rs. 34,96,15,640. No cash impact; EPS diluted proportionally. Action confirms capital restructuring plan.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Earnings per share diluted by 50% due to share count doubling without proportional earnings increase
  • No accompanying announcement of dividend or earnings growth; standalone capital restructuring
📅 Company Track Record
Record date announced 17 March 2026. Board allotment approved 25 March 2026. This is completion of previously intimated bonus plan with final share count and capital structure confirmed.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.